Mariner’s Cantel Medical Corporation CMD Stock Holding History

Mariner’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,020	Closed	-$216K	–	597
2016 Q1	$216K	Buy	+3,020	New	+$190K	0.01%	459

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mariner's CMD Position: Q2 2016 in Review

Mariner sold out of Cantel Medical Corporation (CMD) in Q2 2016, closing a stake of 3,020 shares — an estimated $216K sold.

Mariner first reported a position in CMD in Q1 2016 and held it in 1 quarter. The position peaked at $216K in Q1 2016. 231 funds tracked by Wall St. Rank hold CMD as of Q2 2016.

Mariner reported no remaining Cantel Medical Corporation position as of Q2 2016 after selling out during the quarter.
Mariner sold 3,020 Cantel Medical Corporation shares in Q2 2016, an estimated $216K.
Mariner first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 1 quarter.
Mariner's Cantel Medical Corporation position peaked at $216K in Q1 2016.
231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2016.

Based on Mariner's 13F filing for Q2 2016, filed 12 Aug 2016.